These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39066297)

  • 1. Immunogenicity of a Rotavirus VP8* Multivalent Subunit Vaccine in Mice.
    Cárcamo-Calvo R; Boscá-Sánchez I; López-Navarro S; Navarro-Lleó N; Peña-Gil N; Santiso-Bellón C; Buesa J; Gozalbo-Rovira R; Rodríguez-Díaz J
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
    Xue M; Yu L; Che Y; Lin H; Zeng Y; Fang M; Li T; Ge S; Xia N
    Vaccine; 2015 May; 33(22):2606-13. PubMed ID: 25882173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.
    Velasquez DE; Jiang B
    Hum Vaccin Immunother; 2019; 15(12):3003-3008. PubMed ID: 31124743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model.
    Xue M; Yu L; Jia L; Li Y; Zeng Y; Li T; Ge S; Xia N
    Hum Vaccin Immunother; 2016 Nov; 12(11):2959-2968. PubMed ID: 27435429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity of G1P[8] rotavirus VP7 and VP8* antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq® vaccine.
    Hemming M; Vesikari T
    Infect Genet Evol; 2013 Oct; 19():51-8. PubMed ID: 23831933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence and phylogenetic analyses of human rotavirus strains: comparison of VP7 and VP8(∗) antigenic epitopes between Tunisian and vaccine strains before national rotavirus vaccine introduction.
    Mouna BH; Hamida-Rebaï MB; Heylen E; Zeller M; Moussa A; Kacem S; Van Ranst M; Matthijnssens J; Trabelsi A
    Infect Genet Evol; 2013 Aug; 18():132-44. PubMed ID: 23684631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
    Xia M; Huang P; Jiang X; Tan M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys.
    Luo G; Zeng Y; Sheng R; Zhang Z; Li C; Yang H; Chen Y; Song F; Zhang S; Li T; Ge S; Zhang J; Xia N
    Vaccine; 2024 May; 42(15):3514-3521. PubMed ID: 38670845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
    Fix AD; Harro C; McNeal M; Dally L; Flores J; Robertson G; Boslego JW; Cryz S
    Vaccine; 2015 Jul; 33(31):3766-72. PubMed ID: 26065919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.
    Wen X; Cao D; Jones RW; Li J; Szu S; Hoshino Y
    Vaccine; 2012 Sep; 30(43):6121-6. PubMed ID: 22885016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast expression of the VP8* fragment of the rotavirus spike protein and its use as immunogen in mice.
    Andrés I; Rodríguez-Díaz J; Buesa J; Zueco J
    Biotechnol Bioeng; 2006 Jan; 93(1):89-98. PubMed ID: 16193515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
    Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
    J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.
    Bucardo F; Rippinger CM; Svensson L; Patton JT
    Infect Genet Evol; 2012 Aug; 12(6):1282-94. PubMed ID: 22487061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant bivalent subunit vaccine combining truncated VP4 from P[7] and P[23] induces protective immunity against prevalent porcine rotaviruses.
    Tang X; Li S; Zhou J; Bian X; Wang J; Han N; Zhu X; Tao R; Wang W; Sun M; Li P; Zhang X; Li B
    J Virol; 2024 May; 98(5):e0021224. PubMed ID: 38591886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
    Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
    Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.